The efficacy and safety of gemtuzumab ozogamicin (CMA-676) in patients with acute myeloid leukemia in first relapse.

被引：0
|
作者：
Voliotis, D
Mineur, P
Dombret, H
Theobald, M
Boogaerts, M
Löwenberg, B
Sievers, EL
Larson, RA
Estey, E
Diehl, V
Stadtmauer, EA
机构：
[1] Univ Cologne, Clin Internal Med 1, Koeln, Germany
[2] Hop St Joseph, Gilly Charleroi, Belgium
[3] Hop St Louis, Paris, France
[4] Univ Clin Mainz, Mainz, Germany
[5] Univ Ziekenhuis Gasthuisberg, Louvain, Belgium
[6] Dijkzigt Ziekenhuis Rotterdam, Rotterdam, Netherlands
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[10] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
424O
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia
    Baron, Jeffrey
    Wang, Eunice S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (06) : 549 - 559
  • [42] Gemtuzumab ozogamicin -: Treatment of acute myeloid leukemia
    Rabasseda, X
    Graul, A
    Castañer, RM
    DRUGS OF THE FUTURE, 2000, 25 (07) : 686 - 692
  • [43] Gemtuzumab ozogamicin for treatment of acute myeloid leukemia
    Brotelle, Thibault
    Lemal, Richard
    Molucon-Chabrot, Cecile
    Bay, Jacques-Olivier
    Delaunay, Jacques
    Guieze, Romain
    BULLETIN DU CANCER, 2014, 101 (02) : 211 - 218
  • [44] Gemtuzumab ozogamicin in acute myeloid leukemia revisited
    Thol, Felicitas
    Schlenk, Richard F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (08) : 1185 - 1195
  • [45] The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients
    Pagano, L.
    Fianchi, L.
    Caira, M.
    Rutella, S.
    Leone, G.
    ONCOGENE, 2007, 26 (25) : 3679 - 3690
  • [46] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
    Stasi, Roberto
    Evangelista, Maria Laura
    Buccisano, Francesco
    Venditti, Adriano
    Amadori, Sergio
    CANCER TREATMENT REVIEWS, 2008, 34 (01) : 49 - 60
  • [47] Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone
    Hiroko Tsunemine
    Hiroshi Akasaka
    Emiko Ishikawa Sakane
    Kiminari Ito
    Taiichi Kodaka
    Takayuki Takahashi
    International Journal of Hematology, 2014, 99 : 193 - 197
  • [48] Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone
    Tsunemine, Hiroko
    Akasaka, Hiroshi
    Sakane, Emiko Ishikawa
    Ito, Kiminari
    Kodaka, Taiichi
    Takahashi, Takayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 193 - 197
  • [49] Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
    de Vetten, MP
    Jansen, JH
    van der Reijden, BA
    Berger, MS
    Zijlmans, JMJM
    Löwenberg, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) : 277 - 279
  • [50] The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia
    Kell, Jonathan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 377 - 382
12345